Rheinmetall's Split Personality: Record Operational Cadence Meets a Stubbornly Falling Share Price

Rheinmetall shares fall 31% YTD despite strong Q2 results and $764M US Army deal; Bundestag's Dec 9 Arminius vote could reshape backlog.

The disconnect between what Rheinmetall is achieving on the factory floor and what its share price is doing on the trading screen has rarely been starker. Even as the Düsseldorf-based defence group hands over cutting-edge combat vehicles to the US Army and inches closer to a landmark German procurement decision, the stock finds itself pinned near levels that suggest deep investor scepticism.

The equity closed Thursday at €1,072.40, having shed 6.8 percent over a seven-day stretch. That puts the year-to-date decline at 31 percent, leaving the shares a full 47 percent adrift of the €2,007.00 peak touched on 3 October last year. Wednesday's session was particularly bruising — Rheinmetall led the DAX losers with a 3.31 percent drop, slipping beneath key moving averages in what traders attributed to profit-taking and technical pressure rather than any single piece of adverse corporate news. Thursday brought no respite, with the stock easing a further 2.1 percent to €1,068.80.

A Vote That Could Reshape the Backlog

Against this sombre market backdrop, the calendar is pointing toward a potentially transformative moment. The Bundestag is scheduled to take up the "Arminius" programme on 9 December — a planned mega-order for Boxer wheeled vehicle variants that represents one of the largest procurement initiatives in the Bundeswehr's recent history. Should parliament give its blessing, a fixed contract valued at roughly €12.4 billion could be signed within five to ten days.

The full financial contours of the deal extend well beyond the headline vehicle figure. CEO Armin Papperger has indicated a service agreement worth €4 billion in total, of which Rheinmetall's share would be €2 billion. Two additional options could push the combined framework toward €26 billion — a scale that would meaningfully bolster the group's already formidable order pipeline.

The analyst community is clearly watching this catalyst closely. MWB Research, which had downgraded Rheinmetall from "Hold" to "Sell" as recently as early August — criticising a halved investment ratio and a trimmed backlog target — executed a rapid about-face on Wednesday, lifting the stock back to "Hold" while leaving its price objective unchanged at €1,050. The rationale: market expectations for revenue growth have now been sufficiently tempered, and an improving news flow around the end of the month could shift sentiment. The swift reversal underscores just how volatile sell-side opinion on the defence contractor has become.

Deutsche Bank strikes a far more constructive tone. It reaffirmed a "Buy" recommendation on Tuesday with an €1,800 price target, implying substantial upside from current levels. The chasm between those two analyst views — €750 of disagreement — captures the uncertainty surrounding the stock's near-term trajectory.

US Milestones and Drone Certification

The operational narrative, meanwhile, continues to build momentum on multiple fronts. American Rheinmetall, the group's US subsidiary, has delivered the first of eight Lynx XM30 prototypes to the US Army under an Engineering and Manufacturing Development contract worth $764 million. The programme, part of the Next-Generation Infantry Combat Vehicle initiative, ranks among the US Army's most significant procurement efforts, and Rheinmetall's progress positions it well in a competition that could yield substantial production volumes.

The US push extends beyond the flagship vehicle programme. Kongsberg Defence & Aerospace has awarded American Rheinmetall a contract worth approximately $710,000 for machined components of the MCT-30 turret, with manufacturing slated for the Lapeer and Lansing facilities in Michigan through 2026/2027. While modest in value, the order broadens Rheinmetall's US customer base beyond its existing military business.

Closer to home, the group is advancing its unmanned aerial capabilities. The Bundeswehr Aviation Office has granted a provisional airworthiness certificate for the LUNA NG reconnaissance drone — an interim step toward full type certification. That regulatory progress coincides with industrial expansion: roughly a week ago, Rheinmetall announced plans for a new technology and logistics centre at Kassel Airport, positioning the site as a hub for armoured vehicle activities in Germany.

The infrastructure pipeline also extends to the Bundeswehr's forward presence. Rheinmetall has secured its first contract for a modular camp under the Contractor Augmentation Program II, supporting stationary accommodation in Lithuania — a project that underscores the group's role in NATO's eastern flank posture.

The Numbers Beneath the Noise

The most recent quarterly figures offer a reminder that the operational engine remains robust. Second-quarter revenue climbed roughly 69 to 70 percent to €3.289 billion, while operating profit more than doubled to €562 million, translating to a 17.1 percent margin. The order book expanded 44 percent to surpass €80 billion, buttressed by a €6 billion package from Romania and the €12.4 billion vehicle contract.

There are, however, caveats. The group trimmed its full-year guidance by €300 million to a range of €13.7 billion to €14.2 billion following the cancellation of its participation in the F126 frigate project, though organic growth expectations of 28 to 31 percent remain intact. Late August also brought a Bundeswehr order worth more than €500 million for mobile rescue stations, lifting the total to 165 systems valued at over €600 million.

The technical picture offers little immediate comfort. The Relative Strength Index sits at 40.3 — not yet signalling oversold conditions, but reflecting persistently weak market sentiment. For investors, the calculus is straightforward: Rheinmetall's operational cadence is delivering tangible results across vehicles, drones, and infrastructure, yet the share price continues to bleed. Whether the Arminius decision in December provides the catalyst to finally close that gap — or whether the market's caution proves more durable than the company's momentum — remains the central question hanging over the stock.